A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)

Clinical trial NCT06051721 · COMPLETED

Trial details

NCT number: NCT06051721
Sponsor: Cybin IRL Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2024-05-10
Primary completion: 2025-10-14
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.